A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...
Nanomedicine. 2013;8(6):983-993. Fan and coworkers reported novel multicolor fluorescent Apt–AuNPs for homogeneous detection of small-molecule targets. [45] First, the multicolor dye-labeled aptamers ...
The gold-standard method for detecting viruses is based on reverse transcription polymerase chain reaction (RT-PCR). But this tends to be time-consuming and expensive, and its high sensitivity can ...
Researchers at Osaka Metropolitan University along with their international collaborators report that they have developed a nanofluidic device capable of capturing single proteins stochastically and ...
Researchers show that an anti-nucleolin DNA aptamer modulates gene expression and nucleolin localization to determine a cell’s lineage during differentiation Generating specific cell lineages from ...
Japanese researchers discover iSN04, a DNA aptamer, guiding stem cell differentiation into cardiomyocytes, offering economical potential for regenerative medicine and personalized therapies.
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce an extension of its partnership with Unilever to enter ...
(RTTNews) - Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications.
A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product. Aptamer Group announced on Nov. 7, 2024 that one of its customers has advanced use ...
The HupB protein was discovered in late 1990s by Prof. H. Krishna Prasad, formerly with AIIMS, while looking at specific TB bacterial antigens that induced immune response in humans. He found the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results